Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-028516
Filing Date
2016-08-10
Accepted
2016-08-10 16:50:55
Documents
1
Period of Report
2016-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5475
  Complete submission text file 0001179110-16-028516.txt   6841
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 161822053